🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lucas Michon

Université Claude Bernard Lyon 1

ORCID: 0000-0002-1839-4656

Also affiliated with École Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, Inserm, Centre Léon Bérard, Intermutualist Agency, Centre de Recherche en Cancérologie de Lyon

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer”.

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.22.457244

N/A

0DataRank · unranked

2 citations

Jonathan Zorea, Sankar Jagadeeshan, Avital Beeri Shnerb, Jebrane Bouaoud, Lucas Michon +24 more

PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0521

N/A

0DataRank · unranked

79 citations

Ivan Bièche, Éric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon +51 more

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003917

N/A

0DataRank · unranked

70 citations

Jonathan Zorea, Sankar Jagadeeshan, Avital Beeri Shnerb, Sooraj Mathukkada, Jebrane Bouaoud +27 more